期刊文献+

头顶一颗珠对岗田酸致阿尔茨海默病大鼠脑组织抗氧化酶和过氧化脂质的影响 被引量:8

The effect of TTM on anti-oxidase and lipase peroxide in brain tissues of Alzheimer disease rats induced by okadiac acid
在线阅读 下载PDF
导出
摘要 目的观察头顶一颗珠(TTM)对阿尔茨海默病(AD)模型大鼠海马、皮质抗氧化酶和过氧化脂质表达的影响。方法用岗田酸(OA)大鼠侧脑室注射制备大鼠阿尔茨海默病大鼠模型,TTM注射液(750、500、250 mg/kg)腹腔注射,并用维生素C(V it C)腹腔注射作阳性对照。测定正常组、模型组、阳性对照组、药物实验组海马、皮质超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)和丙二醛(MDA)的含量。结果模型组与正常组比较,SOD、GSH-Px降低(P<0.05,P<0.001),MDA增高(P<0.001)。药物实验组与阳性对照组比较,SOD、GSH-Px和MDA在TTM高、中剂量组差异明显(P<0.05),低剂量组差异不明显(P>0.05)。结论TTM抗衰老作用与增强脑组织SOD、GSH-Px活性、减少MDA蓄积有关。 Objective To observe the effect of trillium tschonoskii maxim (TTM) on anti-oxidase and lipase peroxide (LPO) ex- pression in gyrus hippoeampi and cerebral cortex of Alzheimer disease (AD) rats model. Methods AD model rats were made by injection okadiac acid (OA) via lateral ventricles. Positive control group were given TTM and vitmin C by peritoneal injection. The contents of SOD, GSH-Px, MDA in gyrus hippocampi and cerebral cortex of normal, model, positive control and experimental groups were determined. Results Compared normal group, model group had the reduced SOD and GSH-Px ( P 〈 0. 01 or P 〈 0. 05 ) , and the increased MDA ( P 〈 0. 001 ). Compared with positive control group, experimental group had significant difference in SOD, GSH-Px and MDA between high and moderate dose group( P 〈0. 05 ), but had obvious or had no obvious difference between low dose group (P 〈 0. 05 or P 〉 0. 05 ). Conclusions TTM delaying aging might be associated with the increased SOD, GSH-Px activity and reduced MDA, in brain tissues.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2008年第18期1771-1772,共2页 Chinese Journal of Gerontology
基金 湖北省重点实验室资助项目(课题2006-A03)
关键词 头顶一颗珠 阿尔茨海默病 岗田酸 超氧化物歧化酶 谷胱甘肽过氧化物酶 丙二醛 Trillium tschonoskii maxim (TTM) Alzheimer disease (AD) Okadiac acid (OA) SOD GSH-Px MDA
  • 相关文献

参考文献4

  • 1谢宗万.全国中草药汇编[M].上册.北京:人民卫生出版社,2000:225-6.
  • 2江苏新医学院.中药大词典[M].上册.上海:上海科学技术出版社.1986:834-5.
  • 3高峰,周苏娅,夏强,罗建红.侧脑室注射白细胞介素-2的心血管效应[J].中国应用生理学杂志,2005,21(2):156-159. 被引量:5
  • 4Balaban RS,Nemoto S,Finkel T. Mitochondria,oxidants ,and aging[J]. Cell, 2005;120(4) :483-4.

二级参考文献10

  • 1Tio R A, Nieken J, de Vries E G, et al. Negative inotropic effects of recombinant interleukin 2 in patients without left ventricular dysfunction [ J ]. Eur J Heart Fail, 2000, 2(2): 167-173.
  • 2Jiang C L, Lu C L. Interleukin-2 and its effects in the central nervous system[J]. Biol Signals Recept, 1998,7(3): 148-156.
  • 3Ye J H, Tao L, Zalcmam S S, et al. Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons [ J ]. Brain Research, 2001, 894:241-248.
  • 4Otero G C, Merrill J E. Cytokine receptors on glial cells[J]. Glia, 1994, 11(2): 117-128.
  • 5Seto D, Kar S, Quirion R. Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices[J]. BrJ Pharmacol, 1997, 120(6):1151-1157.
  • 6Jiang C L, Xu D, Lu C L, et al. Interleukin-2: structural and biological relatedness to opioid peptides [ J ].Neuroimmunomodulation, 2000, 8 ( 1 ): 20-24.
  • 7Song P, Lie-Cheng W, Wang G D, et al. Interleukin-2 regulates membrane potentials and calcium channels via mu opioid receptors in rat dorsal root ganglion neurons[J]. Neuropharmacol, 2002, 43(8): 1324-1329.
  • 8Cao C M, Xia Q, Tu J, et al. Cardioprotection of Interleukin-2 is Mediated via {kappa }-Opioid Receptors[J]. JPharmacol Exp Ther, 2004, 309(2): 560-567.
  • 9Raber J, Koob G F, Bloom F E. Interleukin-2 (IL-2)induces corticotropin-releasing factor(CRF) release from the amygdala and involves a nitric oxide-mediated signaling: comparison with the hypothalamic response[J]. J Pharmacol Exp Ther , 1995, 272(2): 815-824.
  • 10Ando T, Dunn A J. Mouse tumor necrosis factor-alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice [ J ]. Neuroimmunomodulation, 1999, 6 ( 5 ):319-329.

共引文献4

同被引文献78

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部